167 related articles for article (PubMed ID: 18226340)
1. [Subcellular distribution and translocation of hepatitis B virus core protein in HepG2.2.15 cells].
Pan XB; Han JC; Wei L; Peng DD; Gao Y
Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):29-32. PubMed ID: 18226340
[TBL] [Abstract][Full Text] [Related]
2. [Cyclosporine A improves the nuclear entry of hepatitis B virus core protein in HepG2.2.15 cells].
Pan XB; Han JC; Gao Y; Wei L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):310-2. PubMed ID: 18322586
[TBL] [Abstract][Full Text] [Related]
3. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
[TBL] [Abstract][Full Text] [Related]
4. [Comparisons of the characteristics and mechanisms of HBV replication in QSG-7701 and HepG2 cell lines].
Pan XB; Zhu L; Gao Y; Chen HS; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):83-7. PubMed ID: 17362629
[TBL] [Abstract][Full Text] [Related]
5. Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro.
Gerber MA; Sells MA; Chen ML; Thung SN; Tabibzadeh SS; Hood A; Acs G
Lab Invest; 1988 Aug; 59(2):173-80. PubMed ID: 2841537
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B core and surface antigens in liver tissue. Light and electron microscopic localization by the peroxidase-labeled antibody method.
Yamada G; Nakane PK
Lab Invest; 1977 Jun; 36(6):649-59. PubMed ID: 325296
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of hepatitis B virus core antigen in a transformed yeast cell: analysis with an inducible system.
Yamaguchi M; Miyatsu Y; Horikawa Y; Sugahara K; Mizokami H; Kawase M; Tanaka H
J Electron Microsc (Tokyo); 1994 Dec; 43(6):386-93. PubMed ID: 7722431
[TBL] [Abstract][Full Text] [Related]
8. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
9. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
Ramakrishna B; Mukhopadhya A; Kurian G
J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
[TBL] [Abstract][Full Text] [Related]
10. [Dynamic analysis of HBV cccDNA in HepG2 cells infected with Ad-1.2 HBV].
Liang WF; Liu ZH; Yang J; Luo KX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1374-5. PubMed ID: 17884782
[TBL] [Abstract][Full Text] [Related]
11. [Study on the replication of Hepatitis B Virus in primary hepatocytes from heterogenous species].
Yao YQ; Zhang DF; Huang AL; Tang N; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):25-8. PubMed ID: 14761278
[TBL] [Abstract][Full Text] [Related]
12. Correlation of hepatitis B core antigen and beta-catenin expression on hepatocytes in chronic hepatitis B virus infection: relevance to the severity of liver damage and viral replication.
Kim CW; Yoon SK; Jung ES; Jung CK; Jang JW; Kim MS; Lee SY; Bae SH; Choi JY; Choi SW; Han NI; Lee CD
J Gastroenterol Hepatol; 2007 Sep; 22(9):1534-42. PubMed ID: 17559383
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.
Liu CJ; Jeng YM; Chen CL; Cheng HR; Chen PJ; Chen TC; Liu CH; Lai MY; Chen DS; Kao JH
J Infect Dis; 2009 Mar; 199(5):742-9. PubMed ID: 19199543
[TBL] [Abstract][Full Text] [Related]
15. Assembly and export determine the intracellular distribution of hepatitis B virus core protein subunits.
Weigand K; Knaust A; Schaller H
J Gen Virol; 2010 Jan; 91(Pt 1):59-67. PubMed ID: 19741067
[TBL] [Abstract][Full Text] [Related]
16. [Anti-HBV effects of genetically engineered replication-defective HBV with combined expression of antisense RNA and dominant negative mutants of core protein and construction of first-generation packaging cell line for HBV vector].
Sun DX; Hu DR; Wu GH; Hu XL; Li J; Fan GR
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):260-4. PubMed ID: 12223133
[TBL] [Abstract][Full Text] [Related]
17. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
[TBL] [Abstract][Full Text] [Related]
18. Replication and infectivity of hepatitis B virus in HBV-related glomerulonephritis.
Chen L; Wu C; Fan X; Gao J; Yin H; Wang T; Wu J; Wen SW
Int J Infect Dis; 2009 May; 13(3):394-8. PubMed ID: 19036623
[TBL] [Abstract][Full Text] [Related]
19. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]